- Home
- HSCS vs ADXN Comparison
HSCS vs ADXN Comparison
Compare HSCS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- ADXN
- Stock Information
- Founded
- HSCS 2007
- ADXN 2002
- Country
- HSCS United States
- ADXN Switzerland
- Employees
- HSCS N/A
- ADXN N/A
- Industry
- HSCS Medical Specialities
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- ADXN Health Care
- Exchange
- HSCS Nasdaq
- ADXN Nasdaq
- Market Cap
- HSCS 8.7M
- ADXN 8.0M
- IPO Year
- HSCS 2022
- ADXN N/A
- Fundamental
- Price
- HSCS $3.33
- ADXN $8.09
- Analyst Decision
- HSCS Strong Buy
- ADXN Strong Buy
- Analyst Count
- HSCS 2
- ADXN 1
- Target Price
- HSCS $13.00
- ADXN $30.00
- AVG Volume (30 Days)
- HSCS 80.2K
- ADXN 683.0
- Earning Date
- HSCS 09-09-2025
- ADXN 09-01-2025
- Dividend Yield
- HSCS N/A
- ADXN N/A
- EPS Growth
- HSCS N/A
- ADXN N/A
- EPS
- HSCS N/A
- ADXN 0.10
- Revenue
- HSCS $4,350.00
- ADXN $278,508.00
- Revenue This Year
- HSCS $13,968.97
- ADXN $86.57
- Revenue Next Year
- HSCS $166.67
- ADXN N/A
- P/E Ratio
- HSCS N/A
- ADXN $0.73
- Revenue Growth
- HSCS N/A
- ADXN N/A
- 52 Week Low
- HSCS $2.36
- ADXN $6.51
- 52 Week High
- HSCS $6.47
- ADXN $11.84
- Technical
- Relative Strength Index (RSI)
- HSCS 43.80
- ADXN 47.89
- Support Level
- HSCS $3.24
- ADXN $7.51
- Resistance Level
- HSCS $3.59
- ADXN $8.21
- Average True Range (ATR)
- HSCS 0.23
- ADXN 0.11
- MACD
- HSCS -0.01
- ADXN 0.00
- Stochastic Oscillator
- HSCS 13.04
- ADXN 47.54
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.